Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Pulmonary Arterial Hypertension Market , by Region, 2019-2027 (USD Billion)
1.2.2. Pulmonary Arterial Hypertension Market , by Drug Class, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pulmonary Arterial Hypertension Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pulmonary Arterial Hypertension Market Dynamics
3.1. Pulmonary Arterial Hypertension Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising incidents of Pulmonary Arterial Hypertension (PAH)
3.1.1.2. Growing geriatric population
3.1.2. Market Restraint
3.1.2.1. Patent expiration of key molecules
3.1.3. Market Opportunities
3.1.3.1. Government support for development of orphan drugs
Chapter 4. Global Pulmonary Arterial Hypertension Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Pulmonary Arterial Hypertension Market , by Drug Class
5.1. Market Snapshot
5.2. Global Pulmonary Arterial Hypertension Market by Drug Class, Performance - Potential Analysis
5.3. Global Pulmonary Arterial Hypertension Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
5.4. Pulmonary Arterial Hypertension Market , Sub Segment Analysis
5.4.1. Prostacyclin And Prostacyclin Analogs
5.4.2. Soluble Guanylate Cyclase (SGC) Stimulators
5.4.3. Endothelin Receptor Antagonist (ERA)
5.4.4. Phosphodiesterase 5 (PDE-5)
Chapter 6. Global Pulmonary Arterial Hypertension Market , Regional Analysis
6.1. Pulmonary Arterial Hypertension Market , Regional Market Snapshot
6.2. North America Pulmonary Arterial Hypertension Market
6.2.1. U.S. Pulmonary Arterial Hypertension Market
6.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
6.2.2. Canada Pulmonary Arterial Hypertension Market
6.3. Europe Pulmonary Arterial Hypertension Market Snapshot
6.3.1. U.K. Pulmonary Arterial Hypertension Market
6.3.2. Germany Pulmonary Arterial Hypertension Market
6.3.3. France Pulmonary Arterial Hypertension Market
6.3.4. Spain Pulmonary Arterial Hypertension Market
6.3.5. Italy Pulmonary Arterial Hypertension Market
6.3.6. Rest of Europe Pulmonary Arterial Hypertension Market
6.4. Asia-Pacific Pulmonary Arterial Hypertension Market Snapshot
6.4.1. China Pulmonary Arterial Hypertension Market
6.4.2. India Pulmonary Arterial Hypertension Market
6.4.3. Japan Pulmonary Arterial Hypertension Market
6.4.4. Australia Pulmonary Arterial Hypertension Market
6.4.5. South Korea Pulmonary Arterial Hypertension Market
6.4.6. Rest of Asia Pacific Pulmonary Arterial Hypertension Market
6.5. Latin America Pulmonary Arterial Hypertension Market Snapshot
6.5.1. Brazil Pulmonary Arterial Hypertension Market
6.5.2. Mexico Pulmonary Arterial Hypertension Market
6.6. Rest of The World Pulmonary Arterial Hypertension Market
Chapter 7. Competitive Intelligence
7.1. Top Market Strategies
7.2. Company Profiles
7.2.1. Johnson & Johnson Services, Inc.
7.2.1.1. Key Information
7.2.1.2. Overview
7.2.1.3. Financial (Subject to Data Availability)
7.2.1.4. Product Summary
7.2.1.5. Recent Developments
7.2.2. Gilead Sciences, Inc.
7.2.3. United Therapeutics Corporation
7.2.4. Acceleron Pharma, Inc.
7.2.5. GlaxoSmithKline Plc. (GSK)
7.2.6. Pfizer, Inc.
7.2.7. Bayer AG
7.2.8. Novartis International AG
7.2.9. Dong-A ST Co., Ltd.
7.2.10. Merck Sharp & Dohme Corp.

Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption